MERIT MEDICAL SYSTEMS INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $20.1m
$27.5m +36.79%
$42.0m +52.66%
$5.5m -87.03%
($9.8m) -280.57%
$48.5m +592.27%
$74.5m +53.79%
$94.4m +26.70%
$120.4m +27.48%
$128.5m +6.76%
Depreciation, Depletion and Amortization $43.8m $53.6m $69.5m $92.1m $94.1m $84.1m $81.8m $90.0m $102.7m $123.2m $135.9m
Depreciation $24.5m $26.8m $28.3m $31.4m $35.4m $34.5m $33.4m $34.0m $37.2m $38.2m $135.9m
Amortization of Debt Issuance Costs $952k $685k $804k $721k $604k $604k $604k $1.7m $6.8m $5.7m
Amortization of Intangible Assets $19.3m $26.8m $41.2m $60.7m $58.6m $49.6m $48.4m $56.1m $65.6m $85.1m
Deferred Income Tax Expense (Benefit) ($962k) ($1.3m) $2.1m ($12.4m) ($11.3m) ($4.6m) ($14.9m) ($12.6m) ($14.9m) $5.2m $5.2m
Share-based Payment Arrangement, Noncash Expense $2.5m $4.1m $6.1m $9.4m $14.3m $16.1m $18.0m $21.3m $28.5m $43.5m $45.4m
Share-based Payment Arrangement, Expense $2.5m $4.1m $6.1m $9.4m $14.3m $16.1m $18.0m $21.3m $28.5m $43.5m $45.4m
Equity Method Investment, Other than Temporary Impairment $0 $0 $0
Goodwill and Intangible Asset Impairment $0 $809k $657k $25.6m $36.6m $4.4m $2.3m $506k $456k $313k
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $497k
Impairment of Intangible Assets, Finite-lived $101k $988k $814k $3.3m $28.7m $1.6m $1.7m $0 $0 $0
Operating Lease, Impairment Loss $1.5m $1.4m $0 $0
Nonoperating Income (Expense) ($9.5m) $2.8m ($9.1m) ($13.2m) ($11.7m) ($7.0m) ($4.9m) ($11.9m) ($5.7m) ($13.8m)
Other Nonoperating Income (Expense) ($773k) ($872k) $63k ($537k) ($2.3m) ($2.5m) $966k $1.2m ($711k) ($2.4m)
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts Receivable $6.8m $12.8m $27.5m $17.9m ($10.4m) $8.6m $15.1m $11.9m $13.7m $7.3m ($16.4m)
Increase (Decrease) in Inventories $3.7m $17.8m $28.2m $27.0m ($29.4m) $25.2m $47.9m $32.1m $2.3m $21.6m ($53.5m)
Net Cash Provided by (Used in) Operating Activities $53.6m
$62.7m +17.03%
$86.5m +37.95%
$77.8m -10.08%
$165.3m +112.39%
$147.2m -10.91%
$114.3m -22.37%
$145.2m +27.00%
$220.8m +52.12%
$297.4m +34.68%
$283.4m -4.68%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $32.8m $38.6m $63.3m $78.2m $46.0m $27.9m $45.0m $34.3m $35.1m $81.7m ($83.7m)
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property $19k ($427k) ($625k) ($115k) ($2.2m) ($1.3m) ($380k) ($5.8m) ($1.5m) ($2.3m) ($9.2m)
Payments to Acquire Businesses, Net of Cash Acquired $125.2m $105.6m $301.8m $53.9m $11.0m $7.2m $8.3m $138.3m $320.2m $144.8m ($115.2m)
Net Cash Provided by (Used in) Investing Activities ($159.1m) ($146.8m) ($378.8m) ($134.5m) ($58.7m) ($37.2m) ($57.4m) ($175.3m) ($368.7m) ($247.4m) ($176.8m)
Cash flows from financing activities:
Repayments of Long-term Debt $102.1m $243.2m $522.6m $202.2m $157.0m $206.9m $260.1m ($75.0m)
Proceeds from Issuance of Long-term Debt $219.5m $197.2m $639.1m $246.7m $68.6m $98.4m $215.2m $1.2b $0
Proceeds from Issuance of Common Stock $5.3m $143.8m $215.0m $6.3m $6.6m $21.3m $20.1m $15.6m $40.9m $28.2m $12.8m
Proceeds from (Payments for) Other Financing Activities ($218k) ($61k) ($231k)
Net Cash Provided by (Used in) Financing Activities $121.1m
$96.5m -20.30%
$328.3m +240.13%
$33.5m -89.79%
($95.7m) -385.41%
($98.4m) -2.85%
($60.3m) +38.78%
$559.3m +1028.09%
($60.0m) -110.73%
$16.0m +126.66%
($644k) -104.03%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($23.0m) $12.6m $10.8m ($7.2m) $528.6m ($210.4m) $69.8m $449.9m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($159.1m) ($146.8m) ($378.8m) $44.3m $56.9m $67.8m $60.6m $589.1m $378.8m $448.5m $449.9m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $96k $1.7m ($801k) ($484k) ($2.5m) $985k
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Proceeds from Stock Options Exercised $8.5m $4.8m $5.5m $20.2m $19.0m $14.5m $39.7m $26.8m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $8.9m $7.7m $10.3m $12.4m $10.1m $5.3m $6.3m $14.1m $23.2m $21.0m
Income Taxes Paid, Net $2.3m $6.0m $8.7m $12.1m $8.9m $8.8m $17.1m $31.5m $45.0m $31.4m
Additional Financial Items
Gain (Loss) on Disposition of Business $517k ($1.4m) $431k $249k
Goodwill $211.9m $238.1m $335.4m $353.2m $363.5m $361.7m $359.8m $382.2m $463.5m $506.8m $497k
Income Tax Expense (Benefit) $5.3m $8.4m $7.5m ($3.3m) ($3.4m) $5.5m $8.1m $17.7m $29.6m $42.4m
Interest Expense Nonoperating $31.2m $26.5m
Investment Income, Interest $81k $381k $1.2m
Operating Expenses $230.1m $293.2m $336.2m $416.9m $402.7m $424.4m $431.5m $459.9m $487.6m $553.5m
Operating Lease, Expense $16.8m $16.7m $16.0m $14.2m
Financing Receivable, Credit Loss, Expense (Reversal) $155k ($531k) $82k $287k $798k $1.3m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.